Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Aberrant cytokine expression in COVID-19 patients: Associations between cytokines and disease severity
Yueting Tang, Jiayu Sun, Huaqin Pan, et al.
Cytokine (2021) Vol. 143, pp. 155523-155523
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Routine laboratory parameters, including complete blood count, predict COVID-19 in-hospital mortality in geriatric patients
Fabiola Olivieri, Jacopo Sabbatinelli, Anna Rita Bonfigli, et al.
Mechanisms of Ageing and Development (2022) Vol. 204, pp. 111674-111674
Open Access | Times Cited: 27
Deciphering the balance of IL-6/IL-10 cytokines in severe to critical COVID-19 patients
Mouna Ben Azaiz, Awatef Ben Jemaa, Walid Sellami, et al.
Immunobiology (2022) Vol. 227, Iss. 4, pp. 152236-152236
Open Access | Times Cited: 23
PI3K/Akt/Nrf2 mediated cellular signaling and virus-host interactions: latest updates on the potential therapeutic management of SARS-CoV-2 infection
V. S. Lekshmi, Kumari Asha, Melvin Sanicas, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 14
Cytokine Levels and Severity of Illness Scoring Systems to Predict Mortality in COVID-19 Infection
Sevda Onuk, Hilal Sipahioğlu, Samet Karahan, et al.
Healthcare (2023) Vol. 11, Iss. 3, pp. 387-387
Open Access | Times Cited: 11
Hydroxypropyl-beta-cyclodextrin (HP-BCD) inhibits SARS-CoV-2 replication and virus-induced inflammatory cytokines
Bruno Braz Bezerra, Gustavo Peixoto Duarte da Silva, Sharton Vinícius Antunes Coelho, et al.
Antiviral Research (2022) Vol. 205, pp. 105373-105373
Open Access | Times Cited: 13
Photobiomodulation Improves Serum Cytokine Response in Mild to Moderate COVID-19: The First Randomized, Double-Blind, Placebo Controlled, Pilot Study
Seyed Mehran Marashian, Mohammadreza Hashemian, Mihan Pourabdollah, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
Comparison of systemic inflammatory profiles in COVID-19 and community-acquired pneumonia patients: a prospective cohort study
Elsa D. Ibáñez-Prada, Matthew Fish, Yuli V. Fuentes, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Circulating extracellular particles from severe COVID-19 patients show altered profiling and innate lymphoid cell-modulating ability
Dorian Forte, Roberto Maria Pellegrino, Sara Trabanelli, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Dynamics of Cytokine, SARS-CoV-2-Specific IgG, and Neutralizing Antibody Levels in COVID-19 Patients Treated with Convalescent Plasma
Pornpitra Pratedrat, Duangnapa Intharasongkroh, Jira Chansaenroj, et al.
Diseases (2023) Vol. 11, Iss. 3, pp. 112-112
Open Access | Times Cited: 5
D-dimer levels and characteristics of lymphocyte subsets, cytokine profiles in peripheral blood of patients with severe COVID-19: A systematic review and meta-analysis
Haiyue Zhang, Hua‐Jun Wu, Dongli Pan, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 9
Obesity and diabetes mellitus are associated with SARS-CoV-2 outcomes without influencing signature genes of extrapulmonary immune compartments at the RNA level
Jöran Lücke, Marius Böttcher, M. Nawrocki, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24508-e24508
Open Access | Times Cited: 1
Differential expression of biomarkers in saliva related to SARS-CoV-2 infection in patients with mild, moderate and severe COVID-19
L. Verdiguel-Fernández, René Arredondo‐Hernández, Jesús Andrés Mejía-Estrada, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Th-1, Th-2, Th-9, Th-17, Th-22 type cytokine concentrations of critical COVID-19 patients after treatment with Remdesivir
Kurosh Kalantar, Atefe Ghamar Talepoor, Mahsa Eshkevar Vakili, et al.
Immunobiology (2023) Vol. 228, Iss. 3, pp. 152378-152378
Open Access | Times Cited: 3
Cell type dependent stability and virulence of a recombinant SARS-CoV-2, and engineering of a propagation deficient RNA replicon to analyze virus RNA synthesis
Li Wang, María Adelina Schlie Guzmán, Diego Muñoz‐Santos, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 3
Immunomonitoring of Monocyte and Neutrophil Function in Critically Ill Patients: From Sepsis and/or Trauma to COVID-19
Ivo Udovičić, Ivan Stanojević, Dragan Djordjević, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 24, pp. 5815-5815
Open Access | Times Cited: 8
Role of Inflammatory Markers in Severity, ICU Admission, and Mortality in COVID-19: A Systematic Review and Meta-analysis of 79,934 Patients
Hiwa O. Abdullah, Sadraldin A. Braim, Maria A. Rasool, et al.
Barw Medical Journal (2024)
Closed Access
Circulating inflammatory cytokines predict severity disease in hospitalized COVID-19 patients: a prospective multicenter study of the European DRAGON consortium
Barbara Polese, Marie Ernst, Monique Henket, et al.
Journal of Infection and Public Health (2024) Vol. 17, Iss. 12, pp. 102589-102589
Open Access
Cytokine levels as predictors of mortality in critically ill patients with severe COVID-19 pneumonia: Case-control study nested within a cohort in Colombia
Francisco Molina, Luz Elena Botero, Juan Pablo Isaza, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 3
Serum C1q Levels Have Prognostic Value for Sepsis and are Related to the Severity of Sepsis and Organ Damage
Huan Li, Juanjuan Chen, Yuanhui Hu, et al.
Journal of Inflammation Research (2021) Vol. Volume 14, pp. 4589-4600
Open Access | Times Cited: 4
The Misattributed and Silent Causes of Poor COVID-19 Outcomes Among Pregnant Women
Yossy Machluf, Sherman Rosenfeld, Izhar Ben Shlomo, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 4
Interaktion von körperlichen Veränderungen und psychischen Störungen bei COVID-19. Ein Scoping Review
Hans Rittmannsberger, Martin Barth, Bernd Lamprecht, et al.
Neuropsychiatrie (2023) Vol. 38, Iss. 1, pp. 1-23
Closed Access | Times Cited: 1
Simulation of COVID-19 symptoms in a genetically engineered mouse model: implications for the long haulers
Mahavir Singh, Sathnur Pushpakumar, Nia Bard, et al.
Molecular and Cellular Biochemistry (2022) Vol. 478, Iss. 1, pp. 103-119
Open Access | Times Cited: 2
Simulation of COVID-19 Symptoms in a Genetically Engineered Mouse Model
Mahavir Singh, Sathnur Pushpakumar, Nia Bard, et al.
Research Square (Research Square) (2022)
Closed Access | Times Cited: 1
ДІАГНОСТИЧНА ТА ПРОГНОСТИЧНА ЗНАЧУЩІСТЬ ІМУНОЛОГІЧНИХ МАРКЕРІВ ПРИ ЛЕГКОМУ ТА ТЯЖКОМУ ПЕРЕБІГУ COVID-19: МЕТА-АНАЛІЗ
Mamontova Tv
Immunology and Allergy Science and Practice (2022), Iss. 4, pp. 39-45
Open Access | Times Cited: 1
Cytokine Storm in COVID-19 Patients: Association between cytokines and disease severity
Walaa Sarhan, Sally M. Shalaby, Nahla Zidan, et al.
Zagazig University Medical Journal (2021)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top